IRB Services

For over 30 years, the clinical research community has trusted Schulman to provide high quality IRB reviews and timely, customer-friendly service. Choosing Schulman as your central IRB means:

  • Full Board meetings five days a week

  • Dedicated daily expedited review of qualifying minimal risk protocols

  • One business day turnaround for qualifying new site submissions

  • Phase I experts with streamlined process tailored to Phase I timelines

  • Oncology experts for all phases of oncology research

  • Review of research conducted in Canada
  • Customized IRB services for institutions and academic medical centers

  • Superior FDA Audit history, having completed 6 consecutive audits with no findings since 1987

  • Board fully accredited by AAHRPP

  • Part 11 compliant eTools developed in-house to meet client specifications

  • Real-time electronic delivery of IRB approval documents

  • Dedicated primary points of contact for sponsors and CROs

  • Experienced points of contact for institutions and sites

  • Informed consent consultation and template development

  • Review summary service for international research

  • Rush review service for recruitment and study-related materials

  • Exemption determination

  • Expert Board and staff available for ad-hoc consultation

  • Access to CITI training modules via Schulman’s account

  • Individualized training opportunities in person or via webinar

To learn more about working with Schulman, contact us.